Scott Drummond
About Scott Drummond
Scott Drummond is the Associate Director Quality Site Microbiologist at Bristol Myers Squibb in Summit, New Jersey, with extensive experience in microbiology and aseptic processing.
Current Role at Bristol Myers Squibb
Scott Drummond currently holds the position of Associate Director Quality Site Microbiologist at Bristol Myers Squibb, based in Summit, New Jersey, United States. His responsibilities include overseeing site quality and maintaining microbiological standards essential for pharmaceutical production.
Experience at Johnson & Johnson
Scott Drummond served as a Senior Scientist Aseptic Processing at Johnson & Johnson from 2019 to 2022 in Raritan, NJ. Prior to that, he worked for 5 years as an Aseptic Processing Scientist in the Greater New York City Area. In these roles, he provided leadership and guidance specifically for aseptic processing in cell therapy products, significantly contributing to Johnson & Johnson's aseptic manufacturing businesses.
Career at Novartis
From 2014 to 2017, Scott Drummond worked in Microbiology at Novartis in Holly Springs, NC. During his tenure, he contributed to the microbiological aspects of pharmaceutical production, ensuring compliance with industry standards and enhancing the company's microbial quality controls.
Roles at AMGEN and Alkermes
Scott Drummond held management roles in QC and EM at AMGEN from 2004 to 2014 in West Greenwich, RI. Shortly before his tenure at AMGEN, he worked as a Senior Microbiologist at Alkermes for four months. Both roles contributed to his extensive experience in quality control and environmental monitoring in the pharmaceutical sector.
Educational Background
Scott Drummond studied at the University of the Sciences in Philadelphia, where he obtained a BS in Biology and a Master's degree in Cell Biology & Biotechnology. His academic background laid the foundation for his expertise in microbiology and biotechnology.
Professional Involvement in ASTM Committees
Scott Drummond chairs the ASTM E55.06 committee, which focuses on standards for pharmaceutical and biopharmaceutical manufacturing. He is also an active contributor to the ASTM Microbial/Sterility Assurance committee, where he plays a significant role in developing standards for microbial and sterility assurance in pharmaceutical products. His involvement ensures that current industry practices meet high standards of microbial control and sterility.